{{Rsnum
|rsid=9354308
|Chromosome=6
|position=65855460
|Orientation=plus
|GMAF=0.2815
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;G)
| geno3=(G;G)
| CEU | 35.4 | 47.8 | 16.8
| HCB | 75.2 | 22.6 | 2.2
| JPT | 69.9 | 28.3 | 1.8
| YRI | 38.1 | 48.3 | 13.6
| ASW | 40.4 | 49.1 | 10.5
| CHB | 75.2 | 22.6 | 2.2
| CHD | 77.1 | 22.9 | 0.0
| GIH | 66.3 | 30.7 | 3.0
| LWK | 61.8 | 36.4 | 1.8
| MEX | 62.1 | 34.5 | 3.4
| MKK | 62.8 | 30.1 | 7.1
| TSI | 41.2 | 43.1 | 15.7
| HapMapRevision=28
}}{{PMID Auto GWAS
|PMID=19043545
|Trait=Serum metabolites
|Title=Genetics Meets Metabolomics: A Genome-Wide Association Study of Metabolite Profiles in Human Serum
|RiskAllele=
|Pval=3E-7
|OR=NR
|ORtxt=NR
|OA=1
}}

{{PharmGKB
|RSID=rs9354308
|Name_s=
|Gene_s=-
|Feature=
|Evidence=PubMed ID:19043545; Web Resource:http://www.genome.gov/gwastudies/
|Annotation=GWAS results: Genetics Meets Metabolomics: A Genome-Wide Association Study of Metabolite Profiles in Human Serum. (Initial Sample Size: 284 males; Replication Sample Size: NR); (Region: 6q12; Reported Gene(s): Intergenic; Risk Allele: rs9354308-?); (p-value= 0.0000003).This variant is associated with Serum metabolites.
|Drugs=
|Drug Classes=
|Diseases=
|Curation Level=Non-Curated
|PharmGKB Accession ID=PA164740311
}}

{{GET Evidence
|impact=pathogenic
|qualified_impact=Insufficiently evaluated pathogenic
|inheritance=unknown
|quality_scores=Array
|dbsnp_id=rs9354308
|overall_frequency_n=76
|overall_frequency_d=100
|overall_frequency=0.76
|n_genomes=41
|n_genomes_annotated=0
|n_haplomes=65
|n_articles=0
|n_articles_annotated=0
|in_gwas=Y
|in_pharmgkb=Y
|autoscore=2
|webscore=N
}}

{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Affy GenomeWide 6}}